| Authors | Cyrille Hulin, Meral Beksac, Hugh J Goodman, Ivan Spicka, Adrian Alegre, Miles Prince, Frank Campana, Greg Finn, Solenn Le-Guennec, Sandrine Macé, Stéphane Muccio, Alexandra Tavernier, Marie-Claude Rouchon, Paul G Richardson |
| Journal | Blood cancer journal
(Blood Cancer J)
Vol. 11
Issue 10
Pg. 169
(10 20 2021)
ISSN: 2044-5385 [Electronic] United States |
| PMID | 34671024
(Publication Type: Clinical Trial, Phase III, Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Thalidomide
- Dexamethasone
- pomalidomide
- isatuximab
|
| Topics |
- Aged
- Antibodies, Monoclonal, Humanized
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects)
- Dexamethasone
(administration & dosage, adverse effects)
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma
(drug therapy, immunology)
- Thalidomide
(administration & dosage, adverse effects, analogs & derivatives)
|
